Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62901

1.

The Effect of a Regional Hepatopancreaticobiliary Surgical Program on Clinical Volume, Quality of Cancer Care, and Outcomes in the Veterans Affairs System.

Lau K, Salami A, Barden G, Khawja S, Castillo DL, Poppelaars V, Artinyan A, Awad SS, Berger DH, Albo D, Anaya DA.

JAMA Surg. 2014 Sep 10. doi: 10.1001/jamasurg.2014.1711. [Epub ahead of print]

PMID:
25207711
[PubMed - as supplied by publisher]
2.

Gene mutations in hepatocellular adenomas.

Raft MB, Jørgensen EN, Vainer B.

Histopathology. 2014 Sep 6. doi: 10.1111/his.12539. [Epub ahead of print]

PMID:
25195525
[PubMed - as supplied by publisher]
3.

Hepatobiliary/Pancreas Pathology: SY11-4 CYTOHISTOLOGY OF FOCAL LIVER LESIONS WITH GLANDULAR FEATURES: APPROACH AND PITFALLS.

Wee A.

Pathology. 2014 Oct;46 Suppl 2:S25. doi: 10.1097/01.PAT.0000454136.97082.10.

PMID:
25188110
[PubMed - in process]
4.

DAX-1 Inhibits Hepatocellular Carcinoma Proliferation by Inhibiting β-Catenin Transcriptional Activity.

Jiang HL, Xu D, Yu H, Ma X, Lin GF, Ma DY, Jin JZ.

Cell Physiol Biochem. 2014 Aug 19;34(3):734-742. [Epub ahead of print]

PMID:
25171651
[PubMed - as supplied by publisher]
5.

An indeterminate nodule in the cirrhotic liver discovered by surveillance imaging is a prelude to malignancy.

Beal EW, Albert S, McNally M, Shirley LA, Hanje J, Michaels AJ, Black SM, Bloomston M, Schmidt CR.

J Surg Oncol. 2014 Aug 25. doi: 10.1002/jso.23765. [Epub ahead of print]

PMID:
25155168
[PubMed - as supplied by publisher]
6.

[A case of esophageal squamous cell carcinoma with an adenocarcinoma component that dedifferentiated after chemotherapy].

Nemoto H, Tate G, Umemoto T, Matsubara T, Mizukami H, Saito M, Kigawa G, Matsumiya A, Tanaka J.

Gan To Kagaku Ryoho. 2014 Jul;41(7):909-12. Japanese.

PMID:
25131883
[PubMed - indexed for MEDLINE]
7.

Hyperthermia inhibits recombination repair of gemcitabine-stalled replication forks.

Raoof M, Zhu C, Cisneros BT, Liu H, Corr SJ, Wilson LJ, Curley SA.

J Natl Cancer Inst. 2014 Aug 15;106(8). pii: dju183. doi: 10.1093/jnci/dju183. Print 2014 Aug.

PMID:
25128695
[PubMed - indexed for MEDLINE]
8.

Two-year Carcinogenicity Study in Rats with a Nonnucleoside Reverse Transcriptase Inhibitor.

Nambiar PR, Morton D, Dochterman LW, Houle C, Thomford PJ, Fate G, Bailey SA, Finch GL.

Toxicol Pathol. 2014 Aug 13. pii: 0192623314544381. [Epub ahead of print]

PMID:
25122632
[PubMed - as supplied by publisher]
9.

Treatment of intermediate-stage hepatocellular carcinoma.

Forner A, Gilabert M, Bruix J, Raoul JL.

Nat Rev Clin Oncol. 2014 Sep;11(9):525-35. doi: 10.1038/nrclinonc.2014.122. Epub 2014 Aug 5.

PMID:
25091611
[PubMed - in process]
10.
11.

[Effects of moxibustion at "Ganshu" (BL 18) on serum alpha-fatoprotein and liver livin levels in rats with precancerous lesion of primary hepatocellular carcinoma].

Jia WR, Dong F, Xie XL, Wang P, Zhang QJ, Wang YQ, Hou ZW, Sui MH.

Zhen Ci Yan Jiu. 2014 Jun;39(3):211-5. Chinese.

PMID:
25069198
[PubMed - indexed for MEDLINE]
12.

Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases.

Teerasamit W, Saiviroonporn P, Pongpaibul A, Korpraphong P.

J Med Assoc Thai. 2014 May;97(5):540-7.

PMID:
25065095
[PubMed - indexed for MEDLINE]
13.

Ethnicity as a predictive factor for hepatocellular carcinoma screening among patients in Hawaii.

Ly CL, Wong LL.

Ethn Dis. 2014 Summer;24(3):376-81.

PMID:
25065082
[PubMed - indexed for MEDLINE]
14.

Effect of everolimus on survival in advanced hepatocellular carcinoma after failure of sorafenib: the EVOLVE-1 randomized clinical trial.

Zhu AX, Kudo M, Assenat E, Cattan S, Kang YK, Lim HY, Poon RT, Blanc JF, Vogel A, Chen CL, Dorval E, Peck-Radosavljevic M, Santoro A, Daniele B, Furuse J, Jappe A, Perraud K, Anak O, Sellami DB, Chen LT.

JAMA. 2014 Jul 2;312(1):57-67. doi: 10.1001/jama.2014.7189.

PMID:
25058218
[PubMed - indexed for MEDLINE]
15.

Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice.

Hartwell HJ, Petrosky KY, Fox JG, Horseman ND, Rogers AB.

Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11455-60. doi: 10.1073/pnas.1404267111. Epub 2014 Jul 21.

PMID:
25049387
[PubMed - in process]
16.

Two different diagnoses in one radiological imaging, related or not?

Unnikrishhan, Chandramohan A, Sajith KG, Ramachandran J.

Trop Gastroenterol. 2013 Oct-Dec;34(4):264-5. No abstract available.

PMID:
25046890
[PubMed - indexed for MEDLINE]
17.

Platelet-related phenotypic patterns in hepatocellular carcinoma patients.

Carr BI, Lin CY, Lu SN.

Semin Oncol. 2014 Jun;41(3):415-21. doi: 10.1053/j.seminoncol.2014.04.001. Epub 2014 Apr 23.

PMID:
25023358
[PubMed - indexed for MEDLINE]
18.

Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.

Carr BI, Pancoska P, Giannini EG, Farinati F, Ciccarese F, Ludovico Rapaccini G, Di Marco M, Benvegnù L, Zoli M, Borzio F, Caturelli E, Chiaramonte M, Trevisani F; Italian Liver Cancer Group.

Semin Oncol. 2014 Jun;41(3):406-14. doi: 10.1053/j.seminoncol.2014.04.002. Epub 2014 Apr 24.

PMID:
25023357
[PubMed - indexed for MEDLINE]
19.

Platelets promote liver immunopathology contributing to hepatitis B virus-mediated hepatocarcinogenesis.

Sitia G.

Semin Oncol. 2014 Jun;41(3):402-5. doi: 10.1053/j.seminoncol.2014.04.013. Epub 2014 Apr 24. Review.

PMID:
25023356
[PubMed - indexed for MEDLINE]
20.

Comprehensive study of tumour single nucleotide polymorphism array data reveals significant driver aberrations and disrupted signalling pathways in human hepatocellular cancer.

Liu Y, Wang M, Feng H, Li A.

IET Syst Biol. 2014 Apr;8(2):24-32. doi: 10.1049/iet-syb.2013.0027.

PMID:
25014222
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk